ERBB2 and neoplasm: Here, we demonstrate that CADM1 inhibits SqCC progression via a mechanism involving HER2 and ITGα6β4-mediated STAT3 inhibition (Fig. 7).Our results indicate that the extracellular domain of CADM1 is responsible for suppressing tumour progression, consistent with previous studies of human colorectal cancer cells14, 15.